Abstract

Glucagon-like peptide 1 (GLP-1) improves insulin resistance of adipose tissue in obese humans. However, the mechanism of this effect is unclear. Perturbation of endoplasmic reticulum (ER) homeostasis impairs insulin signaling. We hypothesized that GLP-1 could directly improve insulin signaling in ER-stressed adipocytes. Here, we examined the effects of GLP-1 on ER stress response in fat cells in an obese and insulin-resistant murine model. We found that GLP-1 analog liraglutide reduced ER stress related gene expression in visceral fat cells accompanied by improved systemic insulin tolerance. Consistently, GLP-1 decreased CHOP expression and increased insulin stimulated AKT phosphorylation (p-AKT) in thapsigargin, a ER stress inducer, treated white fat cells differentiated from visceral stromal vascular fraction. We further found blocking CHOP expression increased insulin stimulated p-AKT in ER-stressed fat cells. Of note, we found mTOR signaling pathway contributed to the expression of ATF4 and subsequently the CHOP expression in ER stress response, while GLP-1 inhibited mTOR activity as exemplified by elevated autophagosome formation and increased LC3II/LC3I ratio. These findings suggest that GLP-1 directly modulates the ER stress response partially via inhibiting mTOR signaling pathway, leading to increased insulin sensitivity in adipocytes.

Highlights

  • Intestinal hormone glucagon-like peptide 1 (GLP-1) potentiates insulin secretion in a glucosedependent manner via activating Glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) highly expressed on islet β cells (Drucker, 2006)

  • To ascertain whether GLP-1 receptor (GLP-1R) activation directly regulates the endoplasmic reticulum (ER) stress response in adipocytes, we treated cultured mature rat adipocytes differentiated from stromal vascular fraction (SVF) with thapsigargin (Tg), a pharmacological inducer of ER stress, for 16 hr in the presence or absence of GLP-1

  • Thapsigargin significantly increased the expression of CHOP and GLP-1 suppressed this increase in adipocytes (Figure 1D and Supplementary Figure 1)

Read more

Summary

Introduction

Intestinal hormone glucagon-like peptide 1 (GLP-1) potentiates insulin secretion in a glucosedependent manner via activating GLP-1 receptor (GLP-1R) highly expressed on islet β cells (Drucker, 2006). GLP-1R was widely expressed on non-β cells and exerts metabolic functions including suppression of glucagon secretion, repression of appetite and slowdown of gastric emptying. GLP-1 has shown functions in improvement of insulin resistance (IR) in insulin responsive tissues especially adipose tissue in obese and diabetic animals and humans (Gastaldelli et al, 2016). The mechanism of the effects of GLP-1 on insulin signaling in adipocytes is still unclear. Previous work from our group and others has amplified GLP-1R transcript in differentiated 3T3L1 cell and stromal vascular fraction (SVF) of murine adipose tissue (Liu et al, 2013, 2016).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call